Nordic walking and arm swing asymmetry in people with Parkinson’s disease: protocol for a randomised clinical trial

People with Parkinson’s disease (PD) face disruptions in arm swing (AS) motion during walking, including a reduction in amplitude and an increase in asymmetry. Both conditions are detrimental to gait performance. Nordic walking (NW) is a walking modality that uses poles and can positively affect the...

Full description

Saved in:
Bibliographic Details
Published in:BMJ Open Sport & Exercise Medicine 2024, Vol.10 (2), p.e002029-e002029
Main Authors: Espinoza-Araneda, Jessica, Caparros-Manosalva, Cristian, da Cunha, Maira, Marzuca-Nassr, Gabriel Nasri, Fritz-Silva, Nicole, Pagnussat, Aline S
Format: Article
Language:English
Subjects:
Asymmetry
Clinical trials
Gait
Gait analysis
Intervention
Kinematics
Medical records
Neurological rehabilitation
Nordic Walking
Parkinson disease
Parkinson's disease
Physical therapy
Protocol
Quality of life
Rehabilitation
Upper extremity
Walking
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:People with Parkinson’s disease (PD) face disruptions in arm swing (AS) motion during walking, including a reduction in amplitude and an increase in asymmetry. Both conditions are detrimental to gait performance. Nordic walking (NW) is a walking modality that uses poles and can positively affect the parameters of AS. This study aims to compare an NW with a free walking (FW) protocol and investigate its effects on AS asymmetry, AS amplitude and gait parameters in people with PD. Twenty-eight people with PD, stages 1–3 on the Hoehn and Yahr Scale, will be randomly assigned to the NW training group (n=14) or the FW training group (n=14). The primary outcomes are amplitude asymmetry of AS (%) and AS amplitude (deg). We will also analyse temporospatial measurements during walking, functional mobility and quality of life. Blinded researchers will conduct evaluations at baseline (T0), postintervention (T1) and at 1 month follow-up (T2). Participants will complete 24 supervised NW or FW training sessions for 12 weeks. This is the first study to address the effects of NW on the asymmetry of AS, AS amplitude and its influence on gait parameters. We hypothesise that an NW programme in PD will reduce the asymmetry and increase the AS amplitude during gait to a greater extent than FW. The results of this study may provide new evidence to understand the effects of NW on gait in people with PD. The study was registered in ClinicalTrial.gov (NCT06342271).
ISSN:2055-7647
2055-7647
DOI:10.1136/bmjsem-2024-002029